SCR-LIP-000536 · Claim · machine-readable JSON →
In 76 UK women with lipedema (mean follow-up 25.3 months), liposuction produced significant postoperative improvement across all SF-36 and WHOQOL-BREF domains and all 17 Lipedema Symptom Scale items (P<0.001), but SF-36 physical, social, and general health scores remained below age-matched normative levels.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Improvement in Health-Related Quality of Life and Symptoms Following Lipedema Liposuction: A Longitudinal Study (2025) ✓ verified — refining · cohort · 2025 · reading confidence: high
“liposuction is an effective treatment for improving HRQoL and symptoms in lipedema patients, although it may not completely restore HRQoL to normative levels”
The study reports symptomatic and quality-of-life improvement after liposuction, supporting a modification of disease burden, but explicitly notes it may not fully restore HRQoL to normal levels — a qualified/narrower claim, not a cure, hen
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000028
- 2026-11-20 — consolidated · SQ-LIP-000028: evidence moved to SCR-LIP-000652
- 2026-11-20 — consolidated · SQ-LIP-000041: evidence moved to SCR-LIP-000783